TrialClinical and experimental nephrology2020

Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study.

Tatsuo Hosoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.